Coffee and tea on cardiovascular disease (CVD) prevention

David Chieng; Peter M Kistler

doi:10.1016/j.tcm.2021.08.004

Coffee and tea on cardiovascular disease (CVD) prevention

Trends Cardiovasc Med. 2022 Oct;32(7):399-405. doi: 10.1016/j.tcm.2021.08.004. Epub 2021 Aug 9.

Authors

David Chieng¹, Peter M Kistler²

Affiliations

¹ The Alfred Hospital, Melbourne, Australia; The Baker Heart Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
² The Alfred Hospital, Melbourne, Australia; The Baker Heart Research Institute, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Monash University, Melbourne, Australia. Electronic address: Peter.kistler@baker.edu.au.

PMID: 34384881
DOI: 10.1016/j.tcm.2021.08.004

Abstract

Coffee and tea are amongst the most consumed beverages worldwide, and are the main source of caffeine in adults. In this review we present findings on the effects of habitual coffee and tea consumption on cardiovascular disease (CVD) prevention. Mild-moderate coffee/ caffeine consumption, at 2-3 cups/day, is associated with beneficial effects on metabolic syndrome, including hypertension and diabetes mellitus, although may elevate lipid levels. Furthermore, coffee consumption reduces the risk of coronary heart disease, heart failure, arrhythmia, stroke, CVD and all cause mortality. Higher tea consumption, in particular green tea, confers similar cardiovascular benefits to coffee with 3 cups/day associated with improved survival in population based studies.

Keywords: Arrhythmia; Caffeine; Coffee; Coronary heart disease; Heart failure; Metabolic syndrome; Mortality; Tea.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Caffeine / adverse effects
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Coffee* / adverse effects
Humans
Lipids
Risk Factors
Tea

Substances

Coffee
Lipids
Tea
Caffeine